Clinical Trials and Similar Human Studies
Last updated: 2024 Nov 18
Total hit(s): 21693
S.No.
1
39319285
Regional variations in HIV diagnosis in Japan before and during the COVID-19 pandemic.
Infect Dis Model
2025 Mar
- n/a -
1
2
39550108
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review.
Rheum Dis Clin North Am
2025 Feb
1
3
39550104
The Short and Long of COVID-19: A Review of Acute and Chronic Radiologic Pulmonary Manifestations of SARS-2-CoV and Their Clinical Significance.
Rheum Dis Clin North Am
2025 Feb
1
4
39550106
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients.
Rheum Dis Clin North Am
2025 Feb
1
5
39182703
Diosmetin-7-O-beta-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication.
J Ethnopharmacol
2025 Jan 10
6.8
1
6
39277919
SARS-CoV-2 detection in COVID-19 patients' sample using Wooden quoit conformation structural aptamer (WQCSA)-Based electronic bio-sensing system.
Biosens Bioelectron
2025 Jan 1
9.52
1
7
39546228
Psycho-Neuro-EndocrinE-Immunology Therapy of Cancer, Autoimmunity, Geriatric Disorders, Covid-19, and Hypertension.
Methods Mol Biol
2025
10.71
1
8
38185645
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
9
38195430
Hyperferritinemia as a factor associated with poor prognosis in COVID-19 patients.
Ceska Slov Farm
2024 Winter
0.36
1
10
38988848
Presumed Fourth Nerve Palsy in a Healthy and Asymptomatic Child with COVID-19 Infection.
Iran J Child Neurol
2024 Summer
1
11
38556935
Symptom Exacerbations of Patients Attending a Community Mental Health Center During the COVID-19 Pandemic.
Turk Psikiyatri Derg
2024 Spring
1
12
39359451
COVID-19 associated lung cavitary lesions: A case series.
Caspian J Intern Med
2024 Fall
1.36
1
13
39359433
COVID-19 infection after vaccination.
Caspian J Intern Med
2024 Fall
1.36
1
14
39172714
Hematological, inflammatory and serological responses among COVID-19 patients admitted to intensive care unit.
Future Sci OA
2024 Dec 31
3.25
1
15
39051458
Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
16
39056147
Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
17
38191194
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
18
38374618
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
19
38836382
Patients with advanced cancer were treated with immune checkpoint inhibitors and injected with COVID-19 vaccine to improve their prognosis without increasing pancreatic related adverse events.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
20
38439670
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
21
39171563
The systemic capillary leak syndrome following COVID-19 vaccine.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
22
38832632
Vaccination status and disease severity of COVID-19 in different phases of the pandemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
23
39422261
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
24
39171541
Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
25
39434214
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.
Hum Vaccin Immunother
2024 Dec 31
4.7
1